Syncom Healthcare Ltd - Stock Valuation and Financial Performance

BSE: 533157 | NSE: SYNCOM | Pharmaceuticals & Drugs | Small Cap

Syncom Healthcare Share Price

4.12 0.00 0.00%
as on 28-Jun'21 18:01

DeciZen - make an informed investing decision on Syncom Healthcare

M-Cap below 100cr DeciZen not available

Syncom Healthcare stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
16.5 Cr.
52-wk low:
4
52-wk high:
4.3

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

The key valuation ratios of Syncom Healthcare Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is a good buy now?

No data found

10 Year X-Ray of Syncom Healthcare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
ROCE % 4.8%0.5%1.4%-0.9%-0.4%-0.7%-23.7%-43.4%-38.2%-67.3%-
Value Creation
Index
-0.7-1.0-0.9-1.1-1.0-1.1-2.7-4.1NANA-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 75.685.894.163.661.962.952.841.564.1202
Sales YoY Gr.-13.6%9.7%-32.4%-2.8%1.7%-16%-21.4%54.4%-68.9%-
Adj EPS 1.4-0.20.1-1.2-1-0.9-9.3-7.5-2.9-2.9-1.1
YoY Gr.--112.3%NA-2066.7%NANANANANANA-
BVPS (₹) 42.945.843.141.440.639.8192.6-0.2-3.1-4.3
Adj Net
Profit
5.5-0.70.2-4.7-3.9-3.6-37-30.1-11.4-11.7-5
Cash Flow from Ops. -8.3-1011044.711.40.23.95.71.3-0.1-
Debt/CF from Ops. -2.1-0.20.37.92.5152.36.74.418.1-271.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -13.8%-20.2%-27.7%-68.9%
Adj EPS -208.7%NANANA
BVPS-174.7%-159.8%-154.6%NA
Share Price -4.5% 14% 20.9% -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on
Equity %
4.5-0.40.1-2.8-2.4-2.2-31.3-69.5-239.2176.130.4
Op. Profit
Mgn %
7.32.14-4.62.51-4.3-12.4-2.9-9.2-164.9
Net Profit
Mgn %
7.3-0.80.3-7.4-6.3-5.8-70.1-72.4-17.8-58.7-243
Debt to
Equity
0.10.10.20.20.20.20.32.4-26.5-1.9-
Working Cap
Days
403632667685543459480455223363531
Cash Conv.
Cycle
2081871632272102031881066-63-1,340

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Syncom Healthcare Ltd.

Standalone Consolidated
TTM EPS (₹) -1.1 -19.6
TTM Sales (₹ Cr.) 1.9 41.5
BVPS (₹.) -4.3 2.6
Reserves (₹ Cr.) -57 -30
P/BV -0.95 1.57
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 3.95 / 4.33
All Time Low / High (₹) 0.65 / 162.40
Market Cap (₹ Cr.) 16.5
Equity (₹ Cr.) 40
Face Value (₹) 10
Industry PE 47.8

Management X-Ray of Syncom Healthcare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Syncom Healthcare

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Sales75.5985.8494.1463.6161.8662.9252.8441.5364.1219.97
Operating Expenses 74.2384.0390.3966.5260.2962.2955.1346.7465.9921.79
Manufacturing Costs8.6311.6110.1415.9110.0915.713.944.695.301.62
Material Costs48.9857.1168.5835.6934.2531.1135.7324.2040.3712.78
Employee Cost 6.827.366.597.578.178.978.8310.3011.295
Other Costs 9.817.945.087.357.796.506.627.559.032.39
Operating Profit 1.361.813.75-2.911.570.63-2.29-5.21-1.86-1.83
Operating Profit Margin (%) 1.8%2.1%4.0%-4.6%2.5%1.0%-4.3%-12.6%-2.9%-9.2%
Other Income 3.204.032.423.072.982.982.280.440.310.26
Interest 1.962.483.684.184.573.313.100.280.410.29
Depreciation 1.812.312.283.775.344.634.613.742.932.29
Exceptional Items 000000-62.19-56.73-6.51-7.57
Profit Before Tax 0.781.040.21-7.80-5.35-4.33-69.90-65.52-11.42-11.72
Tax -1.850.86-0.02-3.21-1.53-0.807.91000
Profit After Tax 2.630.190.23-4.58-3.82-3.53-77.81-65.52-11.42-11.72
PAT Margin (%) 3.5%0.2%0.2%-7.2%-6.2%-5.6%-147.0%-157.0%-17.8%-58.7%
Adjusted EPS (₹)0.70.10.1-1.2-1.0-0.9-19.5-16.4-2.9-2.9
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20

Equity and Liabilities

Shareholders Fund 171.75183.17172.34167.66163.67160.1676.0710.47-0.90-12.42
Share Capital 40404040404040404040
Reserves 131.75143.17132.34127.66123.67120.1636.07-29.53-40.90-52.42
Minority Interest0000000000
Debt17.6422.1730.6835.8927.5829.9622.831823.9223.65
Long Term Debt2.757.8511.6111.2712.8610.708.344.7611.6911.70
Short Term Debt14.8914.3319.0724.6214.7219.2614.4913.2412.2311.95
Trade Payables8.8026.5043.5818.976.227.6113.0721.3423.065.45
Others Liabilities -0.770.454.174.57-2.42-4.055.3911.053.391.13
Total Liabilities 197.41232.29250.77227.09195.06193.68117.3660.8749.4617.83

Fixed Assets

Gross Block26.2527.2139.0745.3145.6546.8423.9724.1024.2124.19
Accumulated Depreciation8.9311.2013.4417.1522.2026.153.897.6210.5612.81
Net Fixed Assets17.3216.0125.6328.1623.4620.6920.0816.4813.6611.37
CWIP 01.0800000000
Investments 4.024.2690.8190.8190.8190.8136.32000
Inventories11.0312.3319.4912.2113.3113.3510.809.537.092.01
Trade Receivables43.0857.8866.3144.0226.5830.5619.8716.8317.840.25
Cash Equivalents 89.580.291.110.580.801.370.450.561.401.13
Others Assets32.37140.4447.4351.3140.1036.9029.8317.479.473.06
Total Assets 197.41232.29250.77227.09195.06193.68117.3660.8749.4617.83

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Cash Flow From Operating Activity -8.26-100.54103.734.6511.380.203.935.691.32-0.09
PBT 2.630.190.23-4.58-5.35-4.33-69.90-65.52-11.37-11.51
Adjustment 3.805.385.745.258.766.8868.0260.319.452.20
Changes in Working Capital -12.7-106.1197.763.988.23-2.156.7110.93.259.22
Tax Paid -1.99000-0.27-0.20-0.90000
Cash Flow From Investing Activity -2.178.96-108.26-6.421.691.225.10-0.97-0.250.56
Capex -2.17-0.96-11.90-6.630.250.07-2.44-0.13-0.110
Net Investments 0-0.24-86.540-1.01-1.4100-0.760.45
Others 010.16-9.820.212.452.557.54-0.830.620.10
Cash Flow From Financing Activity 84.052.305.351.25-12.88-0.93-9.62-4.85-0.99-0.29
Net Proceeds from Shares 96.75000000000
Net Proceeds from Borrowing 0000000000
Interest Paid -1.96-2.48-3.68-4.18-4.57-3.31-2.87-0.020-0.02
Dividend Paid 0000000000
Others -10.744.789.025.43-8.312.38-6.75-4.83-0.99-0.26
Net Cash Flow 73.61-89.290.82-0.520.190.49-0.60-0.120.080.18
PARTICULARSMar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Ratios
ROE (%)2.120.10.13-2.71-2.33-2.2-66.16-151.43N/AN/A
ROCE (%)1.891.791.9-1.78-0.4-0.54-45.67-94.84N/AN/A
Asset Turnover Ratio0.480.40.390.270.290.320.340.471.160.59
PAT to CFO Conversion(x)-3.14-529.16451N/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days21921524131720816617316099165
Inventory Days52506291757783894783
Payable Days8911318632013481106260201407

Syncom Healthcare Ltd Stock News

Syncom Healthcare Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Syncom Healthcare on 28-Jun-2021 18:01 is ₹4.12.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Jun-2021 18:01 the market cap of Syncom Healthcare stood at ₹16.48.
The latest P/E ratio of Syncom Healthcare as of 28-Jun-2021 18:01 is 0.00.
The latest P/B ratio of Syncom Healthcare as of 28-Jun-2021 18:01 is -0.95.
The 52-week high of Syncom Healthcare is ₹4.33 and the 52-week low is ₹3.95.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Syncom Healthcare is ₹1.86 ( Cr.) .

About Syncom Healthcare Ltd

The Company was originally incorporated as Syncom Healthcare Limited on July 29, 2002 by Registrar of Companies, Maharashtra, Mumbai. The Certificate for Commencement of business was granted on August 2, 2002. The company has been promoted by Ajay Bankda & Jyoti Bankda. The company was formed for manufacturing, marketing & trading of pharmaceuticals formulations under its own brands in Ethical, OTC, Generic and Herbal market segment.

Initially it started its journey with the marketing of the pharmaceuticals products manufactured by others under its own brand and in year 2006, the company set up a State of Art manufacturing unit at Dehradun in Uttarakhand. The unit was commissioned in November, 2006. During the year ended March 31, 2007, the net profit before tax & extra-ordinary items, of the Company increased to Rs.331.38 lakh from Rs.32.20 lakh during the year ended March 31, 2006 due to commencement of manufacturing of the various products in its own manufacturing unit and marketing through a strong distribution network.

SHL started as a marketing Company, which was outsourcing its requirement of finished products (Under Its Own Brand And Drug License) from other formulation manufacturing units based in and around Indore. Presently also SHL is outsourcing some of its requirement of finished products. With these companies, Syncom has a purchase and sale arrangement where the supplier unit is manufacturing SHL’s products on SHL’s specification and under SHL’s quality control under which SHL controls the quality of raw material, their sourcing by the supplier as well as production in the units of these suppliers. The manufactured goods, manufactured for SHL are sold to SHL on pre-decided order prices for each formulation product so manufactured.

To cater the diversified and increased demand the Company planned to set up its own pharmaceutical manufacturing facilities. Accordingly, the company set up a manufacturing facility at Dehradun in the state of Uttrakhand, which is a Tax free & duty free Zone. The Company set up its Plant at Dehradun and it started the commercial production in November, 2006. Presently Company is Manufacturing, Marketing and Distributing its Pharmaceutical Formulations under own Brands of Ethical, OTC, Generic and Herbal market segment.

Product range of the company:

Syncom has presence in Pharmaceuticals Formulations which can be categorized in 4 broad categories i.e. Generic, OTC, Ethical and Herbal. The company manufactures a range of products such as Ethical drugs, Generic drugs, over the counter drugs (OTC) and Herbal formulations in various dosage forms and markets them under the trade mark ‘Syncom’ which is a registered trademark in the name of Syncom Healthcare Limited. The company also undertakes contract manufacturing for large variety of pharmaceutical formulations for a number of other pharmaceutical companies of national and international repute such as Lupin Limited, Nicholas Piramal India Ltd, Galpha Laboratories Limited, Percos India Pvt. Ltd etc. (under their own brands) located in India.

The company manufactures various dosage forms, which include tablets, capsules, eye/ear drops, ointment and creams and dry syrups. The company has an established product-marketing network covering both metro and minimetro cities, which enable it to reach the existing and potential customers through the network of distributors and dealers spread across the country. For the purpose of marketing the various products, the Company’s business has been categorized as Branded Generic Division, Over the Counter (OTC), Ethical division and Contract Manufacturing Division.

The Company is producing more than 130 products in Generic segment which includes CTZ, Profeed, Nimjet, Divoron, Gentijet, Ciprojet, etc.

Apart form Generic, the Company has developed presence in OTC Segment. The Company is producing more than 40 products in this segment which include Fastac, Q-coril, Triple action, Pandrop, Syncom Gripe Water, etc. Having built-up a presence in Generic & OTC segment and as a measure to expand and grow, the Company has also entered into Ethical segment. Syncom has developed more than 20 products in this segment which includes Fresca, Flusa, Nutone, Busera, etc.

Syncom is also having presence in Herbal segment with around 25 products which includes Patton, Attom, Narisudha, Salony Cream, etc.

Milestones:

  • 2002 - Incorporation of Syncom Healthcare Limited
  • 2002 - Syncom Healthcare Limited started marketing operations
  • 2005 - Commenced setting up of manufacturing facility at Selaqui, Dehradun
  • 2006 - Start of commercial production at Dehradun Industrial Unit for its own marketing
  • 2007 - Entered into agreement for Contract manufacturing with Lupin Limited, Galpha Laboratories, Nicholas Piramal, etc. Pharmaceutical Companies for manufacturing its various range of products.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.